QINLOCK
Identification of Qinlock
| No description |
Google image searchProduct monograph
Active ingredient
ripretinib, 50 MG
DIN: 02500833
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: DECIPHERA PHARMACEUTICALS. LLC
Date: 10-DEC-2020
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
- L01EX19 — RIPRETINIB (ATC/DDD)
